Estimating influenza vaccine effectiveness using routine surveillance data among children aged 6-59 months for five consecutive influenza seasons

被引:16
|
作者
Su, Wei-Ju [1 ,2 ,3 ]
Chan, Ta-Chien [4 ]
Chuang, Pei-Hung [5 ]
Liu, Yu-Lun [1 ]
Lee, Ping-Ing [3 ]
Liu, Ming-Tsan [1 ]
Chuang, Jen-Hsiang [1 ,6 ]
机构
[1] Minist Hlth & Welf, Ctr Dis Control, Taipei 10050, Taiwan
[2] Natl Taiwan Univ, Inst Epidemiol & Prevent Med, Taipei 10764, Taiwan
[3] Natl Taiwan Univ Hosp, Dept Pediat, Taipei 10016, Taiwan
[4] Acad Sinica, Res Ctr Humanities & Social Sci, Taipei 115, Taiwan
[5] Taiwan Fdn Poison Control, Taipei, Taiwan
[6] Natl Yang Ming Univ, Inst Hlth Care Adm, Taipei 112, Taiwan
关键词
Influenza vaccine effectiveness; Case-control studies; Influenza surveillance; LABORATORY-CONFIRMED INFLUENZA; IMMUNIZATION PRACTICES ACIP; TEST-NEGATIVE DESIGN; HEALTHY-CHILDREN; ADVISORY-COMMITTEE; TRIVALENT; EFFICACY; VIRUS; HOSPITALIZATIONS; RECOMMENDATIONS;
D O I
10.1016/j.ijid.2014.11.011
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Objectives: We aimed to estimate the pooled vaccine effectiveness (VE) in children over five winters through data linkage of two existing surveillance systems. Methods: Five test-negative case-control studies were conducted from November to February during the 2004/2005 to 2008/2009 seasons. Sentinel physicians from the Viral Surveillance Network enrolled children aged 6-59 months with influenza-like illness to collect throat swabs. Through linking with a nationwide vaccination registry, we measured the VE with a logistic regression model adjusting for age, gender, and week of symptom onset. Both fixed-effects and random-effects models were used in the meta-analysis. Results: Four thousand four hundred and ninety-four subjects were included. The proportion of influenza test-positive subjects across the five seasons was 11.5% (132/1151), 7.2% (41/572), 23.9% (189/791), 6.6% (75/1135), and 11.2% (95/845), respectively. The pooled VE was 62% (95% confidence interval (CI) 48-83%) in both meta-analysis models. By age category, VE was 51% (95% CI 23-68%) for those aged 6-23 months and 75% (95% CI 60-84%) for those aged 24-59 months. Conclusions: Influenza vaccination provided measurable protection against laboratory-confirmed influenza among children aged 6-59 months despite variations in the vaccine match during the 2004/2005 to 2008/2009 influenza seasons in Taiwan. (C) 2014 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
引用
收藏
页码:115 / 121
页数:7
相关论文
共 50 条
  • [21] Effects of Adverse Events on the Projected Population Benefits and Cost-effectiveness of Using Live Attenuated Influenza Vaccine in Children Aged 6 Months to 4 Years
    Prosser, Lisa A.
    Meltzer, Martin I.
    Fiore, Anthony
    Epperson, Scott
    Bridges, Carolyn B.
    Hinrichsen, Virginia
    Lieu, Tracy A.
    ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE, 2011, 165 (02): : 112 - 118
  • [22] Randomized Controlled Trial of Dose Response to Influenza Vaccine in Children Aged 6 to 23 Months
    Skowronski, Danuta M.
    Hottes, Travis S.
    Chong, Mei
    De Serres, Gaston
    Scheifele, David W.
    Ward, Brian J.
    Halperin, Scott A.
    Janjua, Naveed Z.
    Chan, Tracy
    Sabaiduc, Suzana
    Petric, Martin
    PEDIATRICS, 2011, 128 (02) : E276 - E289
  • [23] Evaluation of the field-protective effectiveness of seasonal influenza vaccine among Korean children aged < 5 years during the 2014-2015 and 2015-2016 influenza seasons: a cohort study
    Kang, Young Kyung
    Oh, Hea Lin
    Lim, Jung Sub
    Lee, Jun Ah
    Kim, Yun Kyung
    Eun, Byung Wook
    Jo, Dae Sun
    Kim, Dong Ho
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2019, 15 (02) : 481 - 486
  • [24] Comparison of immunogenicity and reactogenicity of split versus subunit influenza vaccine in Korean children aged 6-35 months
    Kim, Yun Kyung
    Eun, Byung Wook
    Kim, Nam Hee
    Kang, Eun Kyeong
    Lee, Byung Sub
    Kim, Dong Ho
    Lim, Jung Sub
    SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 2013, 45 (06) : 460 - 468
  • [25] Immunogenicity and safety of quadrivalent inactivated influenza vaccine in children aged 6 to 35 months: A systematic review and meta-analysis
    Wei, Xia
    Tan, Xue
    Guan, Qinghu
    Zhang, Ruizhi
    Lei, Shiguang
    Wei, Shaofeng
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2023, 19 (02)
  • [26] Live-attenuated influenza vaccine effectiveness against hospitalization in children aged 2-6 years, the first three seasons of the childhood influenza vaccination program in England, 2013/14-2015/16
    Boddington, Nicki L.
    Mangtani, Punam
    Zhao, Hongxin
    Verlander, Neville Q.
    Ellis, Joanna
    Andrews, Nick
    Pebody, Richard G.
    INFLUENZA AND OTHER RESPIRATORY VIRUSES, 2022, 16 (05) : 897 - 905
  • [27] Dose effect of influenza vaccine on protection against laboratory-confirmed influenza illness among children aged 6 months to 8 years of age in southern China, 2013/14-2015/16 seasons: a matched case-control study
    Fu, Chuanxi
    Greene, Carolyn M.
    He, Qing
    Liao, Ying
    Wan, Yanmin
    Shen, Jichuan
    Rong, Chao
    Zhou, Suizan
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2020, 16 (03) : 595 - 601
  • [28] Vaccine effectiveness against laboratory-confirmed influenza hospitalizations among young children during the 2010-11 to 2013-14 influenza seasons in Ontario, Canada
    Buchan, Sarah A.
    Chung, Hannah
    Campitelli, Michael A.
    Crowcroft, Natasha S.
    Gubbay, Jonathan B.
    Karnauchow, Timothy
    Katz, Kevin
    McGeer, Allison J.
    McNally, J. Dayre
    Richardson, David
    Richardson, Susan E.
    Rosella, Laura C.
    Simor, Andrew
    Smieja, Marek
    Tran, Dat
    Zahariadis, George
    Kwong, Jeffrey C.
    PLOS ONE, 2017, 12 (11):
  • [29] Estimating influenza vaccine effectiveness using data routinely available in electronic primary care records
    Regan, Annette K.
    Gibbs, Robyn
    Bloomfield, Lauren
    Effler, Paul V.
    VACCINE, 2019, 37 (05) : 755 - 762
  • [30] Estimating vaccine effectiveness against laboratory-confirmed influenza among children and adolescents in Lower Saxony and Saxony-Anhalt, 2012-2016
    Moehl, A.
    Graefe, L.
    Helmeke, C.
    Ziehm, D.
    Monazahian, M.
    Irmscher, H. -M.
    Dreesman, J.
    EPIDEMIOLOGY AND INFECTION, 2018, 146 (01) : 78 - 88